Peter Rhode Insider Profile

4 Followers
Peter Rhode, Chief Scientific Officer and VP of Clinical Operations at HCW Biologics, holds 77.50K shares in HCW Biologics (Ticker: HCWB).
tipranks
Peter Rhode

Peter Rhode
HCW Biologics (HCWB)
Chief Scientific Officer and VP of Clinical Operations

Not Ranked
Peter Rhode has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$29K
100.00%
A breakdown of Peter Rhode's holdings

Insider Roles

HCW Biologics
(HCWB)
Chief Scientific Officer and VP of Clinical Operations
Roles that Peter Rhode holds in companies

Most Profitable Insider Trade

Stock:
HCW Biologics
(HCWB)
Rating:Informative Buy
Date:Jul 23, 2021 - Jul 23, 2022
Return:-54.10%
The most profitable trade made by Peter Rhode

Peter Rhode's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
HCW Biologics
Dec 11, 2023
Chief Scientific Officer and VP of Clinical Operations
Uninformative Buy
1.96K
$28.68K
Success Rate for
HCWB
0 out of 1 profitable transactions on
HCWB
0%
Average Return for
HCWB
Average return per transaction on
HCWB
-54.10%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jul 23, 2021
Informative Buy
$100.00K
-
$8.00
-54.10%
Nov 20, 2023
Uninformative Buy
$2.10K
-
$0.14
Dec 11, 2023
Uninformative Buy
$1.96K
-
$0.14
Jan 19, 2022
Uninformative Buy
$360.07
-
$0.20
List of latest transactions for each holding click on a transaction to see Peter Rhode's performance on stock

Peter Rhode insider profile FAQ

What is the percentage of profitable transactions made by Peter Rhode?
The percentage of profitable transactions made by Peter Rhode is ―.
    What is the average return per transaction made by Peter Rhode?
    The average return per transaction made by Peter Rhode is ―.
      What stocks does Peter Rhode hold?
      Peter Rhode holds: HCWB stocks.
        What was Peter Rhode’s latest transaction?
        Peter Rhode latest transaction was an Uninformative Buy of $1.96K.
          What was Peter Rhode's most profitable transaction?
          Peter Rhode’s most profitable transaction was an Informative Buy of HCWB stock on July 23, 2021. The return on the trade was -54.10%.
            What is Peter Rhode's role in HCW Biologics?
            Peter Rhode's role in HCW Biologics is Chief Scientific Officer and VP of Clinical Operations.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.